Literature DB >> 17765979

The allergic cascade: review of the most important molecules in the asthmatic lung.

Karolien Bloemen1, Sandra Verstraelen, Rosette Van Den Heuvel, Hilda Witters, Inge Nelissen, Greet Schoeters.   

Abstract

Asthma is the most common chronic inflammatory disorder of the airways among children. It is a complex clinical disease characterized by airway obstruction, airway inflammation and airway hyperresponsiveness to a variety of stimuli. The development of allergic asthma exists of three phases, namely the induction phase, the early-phase asthmatic reaction (EAR) and the late-phase asthmatic reaction (LAR). Each phase is characterized by the production and interplay of various cell-derived mediators. In the induction phase, T helper cytokines are important in the development of asthma. Most important mediators in the EAR are preformed mediators, newly synthesized lipid mediators and cytokines that are produced by mast cells. During the LAR, inflammatory molecules are produced by various cell types, such as eosinophils, neutrophils, T cells, macrophages, dendritic cells, and structural cells. Chronical inflammation leads to structural changes of the airway architecture. In this review, the most important mediators involved in the induction phase, the early-phase and late-phase asthmatic reaction are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17765979     DOI: 10.1016/j.imlet.2007.07.010

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  53 in total

1.  The E3 ubiquitin ligase adaptor Ndfip1 regulates Th17 differentiation by limiting the production of proinflammatory cytokines.

Authors:  Hilda E Ramon; Allison M Beal; Yuhong Liu; George Scott Worthen; Paula M Oliver
Journal:  J Immunol       Date:  2012-03-07       Impact factor: 5.422

2.  Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice.

Authors:  Umesh C S Yadav; Amarjit S Naura; Leopoldo Aguilera-Aguirre; Kota V Ramana; Istvan Boldogh; Sanjiv Sur; Hamid A Boulares; Satish K Srivastava
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

3.  Evaluation of Simvastatin and Bone Marrow-Derived Mesenchymal Stem Cell Combination Therapy on Airway Remodeling in a Mouse Asthma Model.

Authors:  Maryam Mohammadian; Hamid Reza Sadeghipour; Iraj Ragerdi Kashani; Gila Pirzad Jahromi; Amene Omidi; Amir Kavian Nejad; Ravie Golchoobian; Mohammad Hossein Boskabady
Journal:  Lung       Date:  2016-05-09       Impact factor: 2.584

Review 4.  Thymic stromal lymphopoietin: a new cytokine in asthma.

Authors:  Yrina Rochman; Warren J Leonard
Journal:  Curr Opin Pharmacol       Date:  2008-04-29       Impact factor: 5.547

Review 5.  Key mediators in the immunopathogenesis of allergic asthma.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Int Immunopharmacol       Date:  2014-06-13       Impact factor: 4.932

Review 6.  Mast cells and eosinophils: the two key effector cells in allergic inflammation.

Authors:  Yael Minai-Fleminger; Francesca Levi-Schaffer
Journal:  Inflamm Res       Date:  2009-05-08       Impact factor: 4.575

7.  Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma.

Authors:  Zhikun Zhang; Pierre Hener; Nelly Frossard; Shigeaki Kato; Daniel Metzger; Mei Li; Pierre Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

8.  Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation.

Authors:  Ines Lindner; Christiane Meier; Angelika Url; Hermann Unger; Andreas Grassauer; Eva Prieschl-Grassauer; Petra Doerfler
Journal:  BMC Immunol       Date:  2010-05-21       Impact factor: 3.615

9.  Deficiency of endothelial heparan sulfates attenuates allergic airway inflammation.

Authors:  Riaz I Zuberi; Xiao Na Ge; Shuxia Jiang; Nooshin S Bahaie; Bit Na Kang; Reza M Hosseinkhani; Elizabeth M Frenzel; Mark M Fuster; Jeffrey D Esko; Savita P Rao; P Sriramarao
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

10.  CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging.

Authors:  Kuti Baruch; Noga Ron-Harel; Hilah Gal; Aleksandra Deczkowska; Eric Shifrut; Wilfred Ndifon; Nataly Mirlas-Neisberg; Michal Cardon; Ilan Vaknin; Liora Cahalon; Tamara Berkutzki; Mark P Mattson; Fernando Gomez-Pinilla; Nir Friedman; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.